These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21538913)

  • 1. Proteomic analysis of urinary upper gastrointestinal cancer markers.
    Husi H; Stephens N; Cronshaw A; MacDonald A; Gallagher I; Greig C; Fearon KC; Ross JA
    Proteomics Clin Appl; 2011 Jun; 5(5-6):289-99. PubMed ID: 21538913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.
    Zinkin NT; Grall F; Bhaskar K; Otu HH; Spentzos D; Kalmowitz B; Wells M; Guerrero M; Asara JM; Libermann TA; Afdhal NH
    Clin Cancer Res; 2008 Jan; 14(2):470-7. PubMed ID: 18223221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
    Liu XP; Shen J; Li ZF; Yan L; Gu J
    Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
    Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
    BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Application of SELDI-TOF-MS technology in study of laryngeal carcinoma biomarkers].
    Xu Y; Huangfu H; Wang B; Cheng Y; Zhang Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Sep; 22(18):820-3. PubMed ID: 19166025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pilot study using SELDI-TOF-MS based proteomic profile for the identification of diagnostic biomarkers of thyroid proliferative diseases.
    Suriano R; Lin Y; Ashok BT; Schaefer SD; Schantz SP; Geliebter J; Tiwari RK
    J Proteome Res; 2006 Apr; 5(4):856-61. PubMed ID: 16602693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of analytical and pre-analytical conditions for MALDI-TOF-MS human urine protein profiles.
    Calvano CD; Aresta A; Iacovone M; De Benedetto GE; Zambonin CG; Battaglia M; Ditonno P; Rutigliano M; Bettocchi C
    J Pharm Biomed Anal; 2010 Mar; 51(4):907-14. PubMed ID: 19939598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Proteomic profiling: the potential of Seldi-Tof for the identification of new cancer biomarkers].
    Solassol J; Marin P; Maudelonde T; Mangé A
    Bull Cancer; 2005 Sep; 92(9):763-8. PubMed ID: 16203265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry.
    Engwegen JY; Gast MC; Schellens JH; Beijnen JH
    Trends Pharmacol Sci; 2006 May; 27(5):251-9. PubMed ID: 16600386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of serum biomarkers for nasopharyngeal carcinoma by proteomic analysis.
    Wei YS; Zheng YH; Liang WB; Zhang JZ; Yang ZH; Lv ML; Jia J; Zhang L
    Cancer; 2008 Feb; 112(3):544-51. PubMed ID: 18085639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Screening urine markers of renal cell carcinoma using SELDI-TOF-MS].
    Wu DL; Wang WJ; Guan M; Jin SB; Jin CR; Zhang YF
    Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(13):1092-5. PubMed ID: 15312509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standardized peptidome profiling of human serum for the detection of pancreatic cancer.
    Zapico-Muñiz E; Farré-Viladrich A; Rico-Santana N; González-Sastre F; Mora-Brugués J
    Pancreas; 2010 Nov; 39(8):1293-8. PubMed ID: 20924310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein profiling of post-prostatic massage urine specimens by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to discriminate between prostate cancer and benign lesions.
    Okamoto A; Yamamoto H; Imai A; Hatakeyama S; Iwabuchi I; Yoneyama T; Hashimoto Y; Koie T; Kamimura N; Mori K; Yamaya K; Ohyama C
    Oncol Rep; 2009 Jan; 21(1):73-9. PubMed ID: 19082445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case-control breast cancer study of MALDI-TOF proteomic mass spectrometry data on serum samples.
    van der Werff MP; Mertens B; de Noo ME; Bladergroen MR; Dalebout HC; Tollenaar RA; Deelder AM
    Stat Appl Genet Mol Biol; 2008; 7(2):Article2. PubMed ID: 18241195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SELDI-TOF MS profiling of plasma proteins in ovarian cancer.
    Wu SP; Lin YW; Lai HC; Chu TY; Kuo YL; Liu HS
    Taiwan J Obstet Gynecol; 2006 Mar; 45(1):26-32. PubMed ID: 17272204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SELDI-TOF-MS of saliva: methodology and pre-treatment effects.
    Schipper R; Loof A; de Groot J; Harthoorn L; Dransfield E; van Heerde W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):45-53. PubMed ID: 17070117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
    Zhang GQ; Du J; Pang D
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
    Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proteomic analysis of prostate cancer using surface enhanced laser desorption/ionization mass spectrometry].
    Pan YZ; Xiao XY; Zhao D; Zhang L; Ji GY; Li Y; He DC; Zhao XJ; Yang BX
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3172-5. PubMed ID: 16405834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperatively molecular staging with CM10 ProteinChip and SELDI-TOF-MS for colorectal cancer patients.
    Xu WH; Chen YD; Hu Y; Yu JK; Wu XG; Jiang TJ; Zheng S; Zhang SZ
    J Zhejiang Univ Sci B; 2006 Mar; 7(3):235-40. PubMed ID: 16502512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.